Central nervous system: A conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia;Le système nerveux central, chef d'orchestre des régulations métaboliques exposé aux dommages de l'hyperglycémie et de l'hypoglycémie.

Diabetes and Metabolism

Volumn 36, Issue SUPPL. 3, 2010, Pages

  Scheen, A J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Brain; Diabetes; Glucose regulation; Hyperglycaemia; Hypoglycaemia; Review; Stroke, Dementia

Indexed keywords

GLUCOSE;

ARTICLE; BODY FAT; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DEMENTIA; DIABETIC NEUROPATHY; DIABETIC PATIENT; ENERGY BALANCE; ENERGY CONSUMPTION; ENERGY EXPENDITURE; ENERGY METABOLISM; GLUCONEOGENESIS; GLUCOSE METABOLISM; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIENT; OBESITY; PROGNOSIS; RECURRENT DISEASE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STROKE;

BRAIN; DEMENTIA; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; SIGNAL TRANSDUCTION; STROKE;

EID: 78650778363     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(10)70464-X     Document Type: Article

References (49)

1. De Fronzo R.A. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009, 58:773-795.
2. Melendez-Ramirez L.Y., Richards R.J., Cefalu W.T. Complications of type 1 diabetes. Endocrinol Metab Clin North Am 2010, 39:625-640.
3. Radermecker R.P., Philips J.C., Jandrain B.J., Paquot N., Lefèbvre P.J., Scheen A.J. Le cerveau, un organe gluco-dépendant. Effets délétères de l'hypoglycémie et de l'hyperglycémi. e. Rev Med Liège 2008, 63:280-286.
4. Sima A.A. Encephalopathies: the emerging diabetic complications. Acta Diabetol 2010, 4:279-293. 47.
5. Stiles M.C., Seaquist E.A. Cerebral structural and functional changes in type 1 diabetes. Minerva Med 2010, 101:105-114.
6. Wrighten S.A., Piroli G.G., Grillo C.A., Reagan L.P. A look inside the diabetic brain: Contributors to diabetes-induced brain aging. Biochim Biophys Acta 2009, 1792:444-453.
7. McIntyre R.S., Kenna H.A., Nguyen H.T., Law C.W., Sultan F., Woldeyohannes H.O., et al. Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders?. Adv Ther 2010, 27:63-80.
8. Nouwen A., Winkley K., Twisk J., Lloyd C.E., Peyrot M., Ismail K., et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010, 53:2480-2486. For the European Depression in Diabetes (EDID) Research Consortium.
9. Scheen A.J., De Hert M.A. Abnormal glucose metabolism in patients treated with antipsychotics. Diabetes Metab 2007, 33:169-175.
10. Laron Z. Insulin and the brain. Arch Physiol Biochem 2009, 115:112-116.
11. Cardoso S., Correia S., Santos R.X., Carvalho C., Santos M.S., Oliveira C.R., et al. Insulin is a two-edged knife on the brain. J Alzheimers Dis 2009, 18:483-507.
12. Chiu S.L., Cline H.T. Insulin receptor signaling in the development of neuronal structure and function. Neural Dev 2010, 5:7.
13. Schwartz M.W., Porte D. Diabetes, obesity, and the brain. Science 2005, 307:375-379.
14. Sandoval D., Cota D., Seeley R.J. The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu Rev Physiol 2008, 70:513-535.
15. Luquet S., Magnan C. The central nervous system at the core of the regulation of energy homeostasis. Front Biosci 2009, 1:448-465.
16. Pénicaud L. The neural feedback loop between the brain and adipose tissues. Endocr Dev 2010, 19:84-92.
17. Lam C.K., Chari M., Lam T.K. CNS regulation of glucose homeostasis. Physiology (Bethesda) 2009, 24:159-170.
18. Thorens B. Glucose sensing and the pathogenesis of obesity and type 2 diabetes. Int J Obes (Lond) 2008, 32(Suppl 6):S62-S71.
19. Buettner C., Camacho R.C. Hypothalamic control of hepatic glucose production and its potential role in insulin resistance. Endocrinol Metab Clin North Am 2008, 37:825-840.
20. Delaere F., Magnan C., Mithieux G. Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity. Diabetes Metab 2010, 36:257-262.
21. Field B.C., Chaudhri O.B., Bloom S.R. Bowels control brain: gut hormones and obesity. Nat Rev Endocrinol 2010, 6:444-453.
22. Williams D.L. Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis. Endocrinology 2009, 150:2997-3001.
23. Burcelin R., Serino M., Cabou C. A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism. Curr Opin Pharmacol 2009, 9:744-752.
24. McCrimmon R. Glucose sensing during hypoglycemia: lessons from the lab. Diabetes Care 2009, 32:1357-1363.
25. Pénicaud L., Fioramonti X., Lorsignol A., Bénani A., Leloup C. La sensibilité cérébrale au glucose. Bull Acad Natl Med 2007, 191:923-931. discussion 932.
26. Pellerin L. Brain energetics (thought needs food). Curr Opin Clin Nutr Metab Care 2008, 11:701-705.
27. Teh M.M., Dunn J.T., Choudhary P., Samarasinghe Y., MacDonald I., O'Doherty M., et al. Evolution and resolution of human brain perfusion responses to the stress of induced hypoglycemia. Neuroimage 2010, 53:584-592.
28. Cryer P.E., Davis S.N., Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003, 26:1902-1912.
29. Amiel S.A. Hypoglycemia: from the laboratory to the clinic. Diabetes Care 2009, 32:1364-1371.
30. Graveling A.J., Frier B.M. Hypoglycaemia: an overview. Prim Care Diabetes 2009, 3:131-139.
31. Gill G.V., Woodward A., Casson I.F., Weston P.J. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes - -the'dead in bed'syndrome revisited. Diabetologia 2009, 52:42-45.
32. Graveling A.J., Frier B.M. Does hypoglycaemia cause cardiovascular events?. Br J Diabetes Vasc Dis 2010, 10:5-13.
33. Bonds D.E., Miller M.E., Bergenstal R.M., Buse J.B., Byington R.P., Cutler J.A., et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010, 340:b4909. doi:10. 1136/bmj.b4909.
34. Sarwar N., Gao P., Seshasai S.R., Gobin R., Kaptoge S., Di Angelantonio E., et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222. Emerging Risk Factors Collaboration.
35. Bejot Y., Rouaud O., Benatru I., Fromont A., Couvreur G., Caillier M., et al. Les apports du registre dijonnais des accidents vasculaires cérébraux en 20 ans d'activité. Rev Neurol (Paris) 2008, 164:138-147.
36. Ray K.K., Seshasai S.R., Wijesuriya S., Sivakumaran R., Nethercott S., Preiss D., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009, 373:1765-1772.
37. Gentile N.T., Siren K. Glycemic control and the injured brain. Emerg Med Clin North Am 2009, 27:151-169.
38. Quinn TJ, Dawson J, Walters MR. Sugar and stroke: cerebrovascular disease and blood glucose control. Cardiovasc Ther 2010;May 13. Epub ahead of print.
39. Kruyt N.D., Biessels G.J., Devries J.H., Roos Y.B. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol 2010, 6:145-155.
40. Sander D., Kearney M.T. Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives. J Neurol 2009, 256:1603-1619.
41. Pasquier F., Boulogne A., Leys D., Fontaine P. Diabetes mellitus and dementia. Diabetes Metab 2006, 32:403-414.
42. Pasquier F. Early diagnosis of dementia: neuropsychology. J Neurol 1999, 246:6-15.
43. Reijmer Y.D., van den Berg E., Ruis C., Jaap Kappelle L., Biessels G.J. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 2010, 26:507-519.
44. McNay E.C., Cotero V.E. Mini-review: impact of recurrent hypoglycemia on cognitive and brain function. Physiol Behav 2010, 100:234-238.
45. Warren R.E., Frier B.M. Hypoglycaemia and cognitive function. Diabetes Obes Metab 2005, 7:493-503.
46. Cukierman-Yaffee T. The relationship between dysglycemia and cognitive dysfunction. Curr Opin Investig Drugs 2009, 10:70-74.
47. de la Monte S.M., Wands J.R. Alzheimer's disease is type 3 diabetes - evidence reviewed. J Diabetes Sci Technol 2008, 2:1101-1113.
48. Bourdel-Marchasson I., Lapre E., Laksir H., Puget E. Insulin resistance, diabetes and cognitive function: consequences for preventative strategies. Diabetes Metab 2010, 36:173-181.
49. Yau P.L., Javier D.C., Ryan C.M., Tsui W.H., Ardekani B.A., Ten S., et al. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia 2010, 53:2298-2306.